Viewing Study NCT05639192


Ignite Creation Date: 2025-12-24 @ 3:25 PM
Ignite Modification Date: 2025-12-27 @ 5:49 AM
Study NCT ID: NCT05639192
Status: TERMINATED
Last Update Posted: 2023-08-29
First Post: 2022-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease
Sponsor: Apogenix GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module